Advertisement

Zusammenfassung

Seit dem ersten Bericht über ein Zusammentreffen von Haut-Xanthomen und Stauungsikterus durch Addison u. Gull (1851) finden sich im Schrifttum in der zweiten Hälfte des 19. Jahrhunderts mehrfach Beschreibungen von Erkrankungen, die durch einen chronischen Ikterus und die Ausbildung von Hautveränderungen, insbesondere Xanthomen, aber auch vitiligo-artigen Bildern gekennzeichnet waren. Erwähnt seien die Arbeiten von Fagge (1873) sowie von Hutschinson et al. (1882). Ein historischer Rückblick findet sich bei del Fiugo (1959).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Addison, T., Gull, W.: On a certain affection of the skin, vitiligoidea plana and vitiligoidea tuberosa, with remarks. Guy’s Hosp. Rep. 1, 265 (1851).Google Scholar
  2. Ahrens, E.H., Kunkel, H.G.: The relationship between serum lipids and skin xanthoma in eighteen patients with primary biliary cirrhosis. J. clin. Invest. 28, 1565 (1949).Google Scholar
  3. Ahrens, E. H., Jr., Payne, M. A., Kunkel, H. G., Eisenmenger, W. J., BlendHeim, S. H.: Seventeen cases of primary biliary cirrhosis. Medicine (Baltimore) 29, 299 (1950).Google Scholar
  4. Aschoff, L.: Die Erkrankungen der steinfreien Gallenwege. Verh. dtsch. Ges. inn. Med. 44, 261 (1932).Google Scholar
  5. Baggenstoss, A. H., Foulk, W. T., Butt, H. R., Bahn, R. C.: The pathology of primary biliary cirrhosis with emphasis of histogenesis. Amer. J. clin. Path. 42, 259 (1964).Google Scholar
  6. Baker, D. H., Harris, R. C.: Congenital absence of the intrahepatic bile ducts. Amer. J. Roentgenol. 91, 875 (1964).PubMedGoogle Scholar
  7. Beermann, B., Ericsson, J.L.E., Hellström, K., Wengle, B., Werner, B.: Transient cholestasis during treatment with ajmalin and chronic xanthomatous cholestasis after administration of ajmalin, methyltestosterone and ethinylestradiol. Acta med. scand. 190,241 (1971).PubMedGoogle Scholar
  8. Berg, P. A.: Serologische Untersuchungen bei Patienten mit alkoholischer Leberschädigung und ihre differentialdiagnostische Bedeutung. Klin. Wschr. 49, 663 (1971).PubMedGoogle Scholar
  9. Berg, P.A., Doniach, D.: Autoimmune Hepatitiden. Dtsch. med. Wschr. 97, 1468 (1972).PubMedGoogle Scholar
  10. Berg, P.A., Doniach, D., Roitt, J. M.: Immunologische Phänomene bei Leberkrankheiten: Die Bedeutung mitochondrialer Antikörper. Klin. Wschr. 47, 1297 (1969a).Google Scholar
  11. Berg, P.A., Doniach, D., Roitt, J. M.: Mitochondrial antibodies in primary biliary cirrhosis. I. Localization of the antigen to mitochondrial membranes. J. exp. Med. 126, 277 (1967).PubMedGoogle Scholar
  12. Berg, P.A., Roitt, T.M., Doniach, D., Horne, R. W.: Mitochondrial antibodies in primary biliary cirrhosis. III. Characterization of the inner-membrane complement fixing antigen. Clin. exp. Immunol. 4, 511 (1969b).Google Scholar
  13. Boden, R. W., Rankin, J. G., Goulston, S.J.M., Morrow, W.: The liver in ulcerative colitis. The significance of raised serum-alkaline-phosphatase levels. Lancet 1959 II, 245.Google Scholar
  14. Bogoch, A., Danis, T.W., Duffy, M.H., Baird, M.M., McRitosh, H.W.: The effect of prednisone in two patients with primary biliary cirrhosis. Canad. med. Ass. J. 82, 248 (1960).PubMedGoogle Scholar
  15. Brandt, K.-H., Brenkhorst, F. B.: The case of a woman suffering from primary biliary cirrhosis for an unusual long time. Folia med. neerl. 15, 240 (1972).PubMedGoogle Scholar
  16. Brunner, G., Lüders, D., Vido, J.: Primär-biliäre Cirrhose bei einem dreijährigen Mädchen. Dtsch. med. Wschr. 97, 1541 (1972a).Google Scholar
  17. Brunner, G., Vido, J., Vido, J., Schmidt, G.: Die Diagnose der primär-biliären Cirrhose. Klinische, biochemische, immunologische und morphologische Befunde. Dtsch. med. Wschr. 97, 1448 (1972b).Google Scholar
  18. Buyssens, N.: La prolifération des canaux biliares et la formation de structures tubulaires au cours des affections hépatiques en pathologie humaine et expérimentale. Rev. belge Path. 29, 5 (1962).PubMedGoogle Scholar
  19. Carey, J.B., Jr.: Lowering of serum bile acid concentration and relief of pruritus in jaundiced patients fed a bile acid sequestering resin. J. Lab. clin. Med. 56, 797 (1960).Google Scholar
  20. Carman, C. T., Giansiracusa, J.E.: Effect of steroid therapy on the clinical and laboratory features of primary biliary cirrhosis. Gastroenterology 28, 193 (1955).PubMedGoogle Scholar
  21. Charcot, J.M., Gombault, A.: Contributions à l’étude anatomique des différents formes de la cirrhose du foie. Arch. Physiol. norm. path. 3, 456 (1876).Google Scholar
  22. Christoffersen, P., Poulsen, H., Scheuer, P.: Bile-duct damage in hepatitis and primary biliary cirrhosis. 5. Meeting Int. Ass. Study of the Liver, Versailles 1972.Google Scholar
  23. Data, D. V., Sherlock, S.: Cholestyramine for long-term relief of the pruritus complicating intrahepatic cholestasis. Gastroenterology 50, 323 (1966).Google Scholar
  24. Data, D. V., Sherlock, S., Scheuer, P.J.: Post-necrotic cirrhosis with chronic cholestasis. Gut 4, 223 (1963).Google Scholar
  25. Del Fiugo, G. A.: On primary cholestatic cirrhosis of the liver. Gastroenterology 91, 155 (1959).Google Scholar
  26. Delmont, I., Lafon, J., Remacle, I.-P.: Treatment of primary biliary cirrhosis by antilymphocyte globulin. Digestion 6, 270 (1972).Google Scholar
  27. Del Prete, D., ConstantinO, M., Doglia, M., Graziina, A., Ajdukiewicz, A., Dudley, F.J., Fox, R.A., Sherlock, S.: Detection of a new serum-antigen in three epidemics of short-incubation hepatitis. Lancet 1970 II, 579.Google Scholar
  28. Dölle, W., Martini, G.A.: Gelbsucht mit Verschlußsyndrom als Leitsymptom bei Virushepatitis, Arzneimittelschäden in der Schwangerschaft und bei Neugeborenen. Acta hepato-Splenol. (Stuttg.) 6, 225 (1959).Google Scholar
  29. Doniach, D., Del Prete, S., Dane, D.S., Walsh, J.H.: Autoimmunity in chronic liver disease and its relation to viral hepatitis. Canad. med. Ass. J. 106 (1972).Google Scholar
  30. Doniach, D., Roitt, I.M., Walker, G.J., Sherlock, Sh.: Tissues antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis, and other liver diseases, and their clinical implications. Clin. exp. Immunol. 1, 237 (1966).PubMedGoogle Scholar
  31. Doniach, D., Walker, J.G., Roitt, I.M., Berg, P.A.: “Autoallergic” Hepatitis. New Engl. J. Med. 282, 86 (1970).PubMedGoogle Scholar
  32. Eppinger, H.: Die Leberkrankheiten. Wien: Springer 1937.Google Scholar
  33. Fagge, C. H.: General xanthelasma or vitiligoidea. Trans. path. Soc. (Lond.) 24, 242 (1873).Google Scholar
  34. Falk, I.: Die primär-biliäre Lebercirrhose (Beziehung zu den Kollagenkrankheiten). Med. Welt (Stuttg.) 1964 I,244.Google Scholar
  35. Feizi, T., Naccarato, R., Doniach, D., Sherlock, S.: Mitochondrial and other tissue antibodies in relatives of patients with primary biliary cirrhosis. Clin. exp. Immunol. 10, 609 (1972).PubMedGoogle Scholar
  36. Findor, J., Bruch Igartua, E., Alonso, A., Domecq, R., Bozzola, C.: Australia antigen and circulating antibodies in chronic aggressive hepatitis. Acta hepato-gastroenterol. 20, 98 (1973).Google Scholar
  37. Finlayson, N. D. C., Krohn, K., Anderson, K. E., Jokelainen, P. T., Prince, A. M.: Interrelations of hepatitis B antigen and autoantibodies in chronic idiopathic liver disease. Gastroenterology 63, 646 (1972b).Google Scholar
  38. Finlayson, N. D. C., Krohn, K., Fanconnet, M.H., Anderson, K.E.: Significance of serum complement levels in chronic liver disease. Gastroenterology 63, 653 (1972a).Google Scholar
  39. Fischer, J.A., Schmidt, M.: Treatment of primary biliary cirrhosis with azathioprine. Lancet 1967 I, 421.Google Scholar
  40. Foulk, U. T., Baggenstoss, A.H.: Biliary cirrhosis. In: Schiff, L.: Diseases of the liver, 3rd ed. Philadelphia-Toronto: Lippincott 1969.Google Scholar
  41. Foulk, U. T., Baggenstoss, A.H., Butt, H. R.: Primary biliary cirrhosis. Reevaluation by clinical and histological study of 49 cases. Gastroenterology 47, 354 (1964).PubMedGoogle Scholar
  42. Fox, R.A., Dudley, F.J., Samuels, M., Milligan, J., Sherlock, Sh.: Lymphocyte transformation in response to phytohaemagglutinin in primary biliary cirrhosis: The search for a plasma inhibitory factor. Gut 14, 89 (1973).PubMedGoogle Scholar
  43. Fox, R.A., James, D.G., Scheuer, P.J., Sharma, O., Sherlock, S.: Impaired delayed hypersensitivity in primary biliary cirrhosis. Lancet 1969 I, 959.Google Scholar
  44. Fox, R.A., Dudley, F.J., Niazi, S. P., Sherlock, Sh.: Hepatitis-associated antigen in chronic liver disease. Lancet 1969 II, 609.Google Scholar
  45. Fredrikson, D. S., Levy, R. J., Lees, R. S.: Fat transport in lipoproteins: an integrated approach to mechanisms and disorders. New Engl. J. Med. 276, 273 (1967).Google Scholar
  46. Galbraith, R.M., Mckenzie, R.M., Smith, M.G.M., Tee, D.S., Doniach, D., Williams, R.: Immunological abnormalities in the relatives of patients with active chronic hepatitis and primary biliary cirrhosis. Digestion 6, 243 (1972).Google Scholar
  47. Gathmann, H.: Beitrag zur Diagnostik der Gallengangsatresie und-hypoplasie bei Kleinkindern. Acta hepato-gastroenterol. 20, 24 (1973).Google Scholar
  48. Glenn, F., Whitsell, J.G.: Primary sclerosing cholangitis. Surg. Gynec. Obstet. 123, 1070 (1966).Google Scholar
  49. Glober, G.A., Wilkerson, J.A.: Biliary cirrhosis following the administration of methyltestosterone. J. Amer. med. Ass. 204, 178 (1968).Google Scholar
  50. Gokcen, M.: Autoimmunity in liver disease. Serologic investigations with clinical correlations. J. Lab. clin. Med. 59, 533 (1962).PubMedGoogle Scholar
  51. Gokcen, M., Zinneman, H. H.: Liver “autoantibodies” in a case of drug-induced jaundice. Gastroenterology 44, 69 (1963).PubMedGoogle Scholar
  52. Goldfarb, S., Singer, E.J., Popper, H.: Experimental cholangitis due to α:-naphthylisothiocyanate (ANIT). Amer. J. Path. 40, 685 (1962).PubMedGoogle Scholar
  53. Golding, P.L., Mason, A.S.M.: Renal tubular acidosis and autoimmune liver disease. Gut 12, 153 (1971).PubMedGoogle Scholar
  54. Goudie, R. B., Macstreen, R. N. M., Goldberg, D. M.: Serological and histological diagnosis of primary biliary cirrhosis. J. clin. Path. 19, 527 (1966).PubMedGoogle Scholar
  55. Gregory, D.H., Zaki, G.F., Sarkoss, G.A., Carey, J.B.: Chronic cholestasis foHowing prolonged tolbutamide administration, associated with distructive cholangitis and cholangiolitis. Arch. Path. 84, 194 (1967).PubMedGoogle Scholar
  56. Hamilton, J.D.: The pathology of primary biliary cirrhosis. Lab. Invest. 8, 701 (1959).PubMedGoogle Scholar
  57. Hanger, F. M., Gutman, A. B.: Postarsphenamine jaundice apparently due to obstruction of intrahepatic biliary tract. J. Amer. med. Ass. 115, 263 (1940).Google Scholar
  58. Hanot, V.: La cirrhose hypertrophique avec ictere chronique. Paris: Rueff et Cie. 1892.Google Scholar
  59. Hellstrom, H. R., Perezstable, E. C.: Retroperitoneal fibrosis with disseminated vasculitis and intrahepatic sclerosing cholangitis. Amer. J. Med. 40, 184 (1966).PubMedGoogle Scholar
  60. Hijeda, K.: Experimentelle Studien über die Pathogenese des Ikterus. „Über die Entstehung des Toluylendiaminikterus“. Beitr. path. Anat. 78, 389 (1927).Google Scholar
  61. Hoffbauer, F. W.: Primary biliary cirrhosis. Observations on the natural course of the disease in 25 women. Amer. J. dig. Dis. 5, 348 (1960).PubMedGoogle Scholar
  62. Holdsworth, C.D., Hall, E.W., Dawson, A.M., Sherlock, S.: Ulcerative colitis in chronic liver disease. Quart. J. Med. 34, 211 (1965).PubMedGoogle Scholar
  63. Holtzman, I.N.: Sarcoidosis followed by biliary cirrhosis and xanthomatosis. N. Y. St. J. Med. 61, 1757 (1961).Google Scholar
  64. Howat, H.T., Ralston, A.J., Varley, H., Wilson, C.A.J.: The late results of long-term treatment of primary biliary cirrhosis by corticosteroids. Rev. int. Hépat. 16, 227 (1966).PubMedGoogle Scholar
  65. Hunt, A.H., Parr, R.M., Taylor, D.M., Trott, N.G.: Relation between cirrhosis and trace metal content of liver with special reference to primary biliary cirrhosis and copper. Brit. med. J. 1963, 5371, 1498.Google Scholar
  66. Hurt, P., Wegmann, T.: Protrahierter Largactilikterus mit Übergang in primäre biliäre Cirrhose. Acta hepato-splenol. 8, 87 (1961).Google Scholar
  67. Hutchinson, J., Sangster, A., Randcliffe, R. H.: Zit. nach Del Fiugo [Trans. path. Soc. (Lond.) 33, 373 (1881)]Google Scholar
  68. Jensen, K.B., Ranek, L.: IgM turnover in primary biliary cirrhosis. Digestion 6, 282 (1972).Google Scholar
  69. Jones, W. A., Tisdale, W. A.: Posthepatic cirrhosis. Clinically simulating extrahepatic biliary obstruction (so-called “primary biliary cirrhosis”). New Engl. J. Med. 12, 629 (1963).Google Scholar
  70. Kalk, H.: Hepatitis und posthepatitische Leberkrankheiten. Verh. dtsch. Ges. inn. Med. 63, 177 (1957).Google Scholar
  71. Kalk, H., Wildhirt, E.: Die Krankheiten der Leber. In: Klinik der Gegenwart, Bd. VII, S. 377. München: Urban & Schwarzenberg 1958.Google Scholar
  72. Kaplan, M.M., Grady, G.: Serum-hepatitis antigen in chronic hepatitis and primary biliary cirrhosis. Lancet 1971 I, 159.Google Scholar
  73. Kaplowitz, N., Finlayson, N., Javitt, N.: Serum bile acids (BA) in anti mitochondrial antibody (AMA) positive liver disease. 23. Meet. Amer. Ass. Study of the liver. Chicago 1972.Google Scholar
  74. Karsner, H.T.: Zit. nach Del Fiugo 1959.Google Scholar
  75. Kattermann, R., Reinold, V. W.: Leberschaden und Lipidstoffwechsel. II. Biosynthese von Cholesterin, Phospholipiden und Glyceriden in der Leber bei der experimentellen Cholestase an der Ratte. Acta hepato-splenol. 17, 75 (1970).Google Scholar
  76. Kehayoglou, A.K., Holdsworth, C.D., Agnew, J.E., Whelton, M.J., Sherlock, S.: Bone disease and calcium absorption in primary biliary cirrhosis. Lancet 1968 I, 715.Google Scholar
  77. Kew, M.C., Varma, R.R., Des Santes, H.A., Scheuer, P.J., Sherlock, S.: Portal hypertension in primary biliary cirrhosis. Gut 12, 830 (1971).PubMedGoogle Scholar
  78. Klion, F. M., Schaffner, F.: Electron microscopic observations in primary biliary cirrhosis. Arch. Path. 81, 152 (1966).PubMedGoogle Scholar
  79. Kohn, N., Myerson, R.M.: Xanthomatous biliary cirrhosis following chlorpromazine. Amer. J. Med. 31, 665 (1961).PubMedGoogle Scholar
  80. Krohn, K., Finlayson, N. D. C., Jokelainen, P. T., Anderson, K. E., Prince, A. M.: Electron microscopial and immunological observations on the serum-hepatitis (S. H.) antigen in primary biliary cirrhosis. Lancet 1970 II, 379.Google Scholar
  81. Kühn, H. A.: Ikterus durch intrahepatische Cholestase bei Brüdern. Acta hepato-splenol. 9, 229 (1962).Google Scholar
  82. Kühn, H. A. Die Pathologie der Ausscheidung der Leber. In: Handbuch der allgemeinen Pathologie, 5. Band, 2. Teil. Berlin-Göttingen-Heidelberg: Springer 1959.Google Scholar
  83. Kühn, H. A., Müller, W., Pfister, R.: Über chronische Cholangiolitis und ihre Beziehung zur primaren biliären Cirrhose. Z. klin. Med. 154, 462 (1957).PubMedGoogle Scholar
  84. Müller, W., Pfister, R. Die primäre biliären Cirrhose. Dtsch. med. Wschr. 82, 627 (1957).PubMedGoogle Scholar
  85. Müller, W., Pfister, R., Nagele, E.: Colitis ulcerosa. Ergebn. inn. Med. Kinderheilk. Neue Folge 25, 165 (1967).Google Scholar
  86. Müller, W., Weinreich, G.: Immunologische Probleme bei chronischer Hepatitis und Lebercirrhose. Dtsch. med. Wschr. 89, 723 (1964).Google Scholar
  87. Kunkel, H.J.: Biliary cirrhosis. In: Schiff (Ed.): Diseases of the liver. Philadelphia: Lippincott 1956.Google Scholar
  88. Kunkel, H.J., Ahrens, E. H., Jr.: The relationship between serum lipids and the electrophoretic pattern with particular reference to patients with primary biliary cirrhosis. J. clin. Invest. 28, 1575 (1949).PubMedGoogle Scholar
  89. Lam, K. C., Mistilis, S. P., Perrot, N.: Positive tissue antibody tests in patients with prolonged biliary obstruction. New Engl. J. Med. 286, 1400 (1972).PubMedGoogle Scholar
  90. Lauda, E.: Die cholangitischen Cirrhosen. Verh. dtsch. Ges. Verdau.-u. Stoffwechselkr. 17, 269 (1954).Google Scholar
  91. Leeson, P. M., Fourman, P.: A disorder of copper metabolism treated with penicillamin in a patient with primary biliary cirrhosis and renal tubular acidosis. Amer. J. Med. 43, 620 (1967).PubMedGoogle Scholar
  92. Leevy, C. M.: Fatty liver — a study of 270 patients with biopsy proven fatty liver on a review of literature. Medicine (Baltimore) 41, 249 (1962).Google Scholar
  93. Leger, L., Premont, M., Neveux, J.-Y., Lemaigre, J.: La place de la splénectomie dans le traitement de la cholestase intra-hépatique chronique. J. Chir. (Paris) 86, 427 (1963).Google Scholar
  94. Levine, R. A., Briggs, G. W., Lobell, D. M.: Chronic chlorpromazine cholangiolitic hepatitis. Gastroenterology 50, 665 (1966).PubMedGoogle Scholar
  95. Mackay, I.R.: Primary biliary cirrhosis. A case with systemic lesions and circulating antitissue antibody. Lancet 1960 II, 521.Google Scholar
  96. Macmahon, H.E.: Biliary xanthomatosis (xanthomatous biliary cirrhosis). Amer. J. Path. 24, 527 (1948).PubMedGoogle Scholar
  97. Macmahon, H.E. Biliary cirrhosis. Differential features of the five types. Lab. Invest. 4, 243 (1955).PubMedGoogle Scholar
  98. Macmahon, H.E., Thannhauser, S. J.: Xanthomatous biliary cirrhosis (a clinical syndrom). Ann. intern Med. 30, 121 (1949).PubMedGoogle Scholar
  99. Macsween, R.N.M., Horne, C.H.W., Moffat, A.J., Hughes, H.H.: Serum protein levels in primary biliary cirrhosis. J. clin. Path. 25, 789 (1972).PubMedGoogle Scholar
  100. Maddrey, W. C., Saito, S., Shulman, N.R., Klatskin, G.: Coincidental Australia antigenemia in primary biliary cirrhosis. Ann. intern. Med. 76, 705 (1972).PubMedGoogle Scholar
  101. Magyar, I., Baky, B., Szalay, F.: Antibodies and HAA-antigen in chronic hepatic diseases. 5. Meeting Intern. Ass. Study of the Liver, Versailles 1972.Google Scholar
  102. Mallory, F. B.: Cirrhosis of the liver. Five different types of lesions from which it may arise. Bull. Johns Hopk. Hosp. 22, 69 (1911).Google Scholar
  103. Massarat, S., Korb, G.: High alkaline phosphatase in chronic non-cholestatic hepatitis. Digestion 6, 217 (1972).Google Scholar
  104. Mendenhall, C.L., Mortisaux, A.: The effects of sodium dextrothyroxin on lipid metabolism in primary biliary cirrhosis. Gastroenterology 42, 411 (1962).PubMedGoogle Scholar
  105. Meyer Zum Büschenfelde, K. H.: Immunpathogenese chronisch-entztindlicher Lebererkrankungen. Erg. inn. Med. Kinderheilk. Neue Folge 32, 31 (1972).Google Scholar
  106. Mistilis, S. P.: Pericholangitis and ulcerative colitis. I. Pathology, Etiology and Pathogenesis. Ann. intern. Med. 63, 1 (1965).PubMedGoogle Scholar
  107. Murphy, G.M., Jansen, F.H., Billing, B.H.: An abnormal bile salt in primary biliary cirrhosis. Gut 12, 771 (1971).Google Scholar
  108. Murray-Lyon, I.M., Thompson, R.P.H., Ansell, I.D.: Scleroderma and primary biliary cirrhosis. Brit. med. J. 1970 III, 258.Google Scholar
  109. Myers, I. D., Olson, R.E., Lewis, J.H., Moran, T.J.: Xanthomatous biliary cirrhosis following chlorpromazine, with observations indicating overproduction of cholesterol, hypoprothrombinemia, and the development of portal hypertension. Trans. Ass. Amer. Phycns 70, 243 (1957).Google Scholar
  110. Myers, R.L., Baggenstoss, A.H., Logan, G.B., Hallenbeck, G.A.: Congenital atresia of the extrahepatic biliary tract: a clinical and pathological study. Pediatrics 18, 707 (1956).Google Scholar
  111. O’Brien, St. T., Eddy, W. M., Krawitt, E. L.: Primary biliary cirrhosis associated with scleroderma. Gastroenterology 62, 118 (1972).PubMedGoogle Scholar
  112. Oka, T.: Zur Pathogenese des Toluylendiaminikterus. Klin. Wschr. 1935 I, 861.Google Scholar
  113. Paronetto, F.: Immunologic aspects of liver diseases. In: Popper, Schaffner (Eds.): Progress in liver diseases 3, 299 (1970).Google Scholar
  114. Paronetto, F., Schaffner, F., Mutter, R.D., Kniffer, J.C., Popper, H.: Circulating antibodies to bile ductular cells in various liver diseases. J. Amer. med. Ass. 187, 503 (1964a).Google Scholar
  115. Paronetto, F., Schaffner, F., Popper, H., Popper, H.: Immunocytochemical and serologic observations in primary biliary cirrhosis. New Engl. J. Med. 271, 1123 (1964b).Google Scholar
  116. Payne, M.A.: Biliary cirrhosis. Med. Clin. N. Amer. 44, 653 (1960).PubMedGoogle Scholar
  117. Pinkard, R.N., Weir, D.M.: Antibodies against the mitochondrial fraction of the liver after toxic liver damage in the rat. Clin. exp. Immunol. 1, 33 (1966).Google Scholar
  118. Popper, H., Schaffner, F.: Nonsuppurative destructive chronic cholangitis and chronic hepatitis. In: Popper, Schaffner (Eds.): Progress in liver diseases 3, 336 (1970).Google Scholar
  119. Poulsen, H., Christoffersen, P.: Abnormal bile duct epithelium in chronic aggressive hepatitis and cirrhosis. — A review of morphology and clinical, biochemical and immunologic features. Hum. Path. 3, 217 (1972).PubMedGoogle Scholar
  120. Rautureau, M., Lemonnier, F., Cheyrel, B.: Les acids biliares dans les cirrhoses biliares primitives. Rev. int. Hepat. 16, 193 (1966).PubMedGoogle Scholar
  121. Read, A.E., Harrison, C.V., Sherlock, S.: Chronic chlorpromazine jaundice, with particular reference to its relationship to primary biliary cirrhosis. Amer. J. Med. 31, 249 (1961).PubMedGoogle Scholar
  122. Reynolds, T. B., Denison, E. K., Frankl, H. D., Lieberman, F. L., Peters, R. L.: Primary biliary cirrhosis with scleroderma, Raynaud’s phenomenon and telangiectasia. New syndrome. Amer. J. Med. 50, 302 (1971).PubMedGoogle Scholar
  123. Reynolds, T. B., Denison, E. K., Frankl, H. D., Lieberman, F. L., Peters, R. L. New syndrome: Combination of primary biliary cirrhosis, scleroderma and hereditary hemorrhagic teliangectasia. Gastroenterology 58, 290 (1970).Google Scholar
  124. Ricketts, W. E., Wissler, R. W.: Cholangiolitic biliary cirrhosis (primary biliary cirrhosis). Ann. intern. Med. 36, 1241 (1952).PubMedGoogle Scholar
  125. Ritland, S., Blomhoff, J. P., Elgjo, K., Gjone, E.: Lipoprotein-X (LP-X) in liver disease. Scand. J. Gastroent. 8, 155 (1973).PubMedGoogle Scholar
  126. Rodriguez, M., Paronetto, F., Schaffner, F., Popper, H.: Antimitochondrial antibodies in jaundice following drug administration. J. Amer. med. Ass. 208, 148 (1969).Google Scholar
  127. Rössle, R.: Die cholangiolitische Cirrhose. In: Handbuch der speziellen pathologischen Anatomie, Bd. V/1, S. 448. Berlin: Springer 1930.Google Scholar
  128. Ross, A., Sherlock, S.: A controlled trial of azathioprine in primary biliary cirrhosis. Gut 12, 770 (1971).Google Scholar
  129. Rubin, E., Schaffner, F., Popper, H.: Localization of the basic injury in primary biliary cirrhosis. J. Amer. med. Ass. 183, 331 (1963).Google Scholar
  130. Rubin, E., Schaffner, F., Popper, H., Primary biliary cirrhosis. Amer. J. Path. 46, 387 (1965).PubMedGoogle Scholar
  131. Ruckstuhl, P., Cueni, B., Schmid, M.: Chronische aggressive Hepatitis in Kombination mit chronisch destruierender, nichteitriger Cholangitis (sogenannte primäre biliäre Cirrhose). Schweiz. med. Wschr. 101, 741 (1971).PubMedGoogle Scholar
  132. Rüttner, J. R., Rondez, R., Maier, C.: Chlorpromazine-Ikterus, eine Form der cholestatischen Hepatose. Dtsch. med. Wschr. 87, 1107 (1962).Google Scholar
  133. Schaffner, F.: Paradoxical elevation of serum cholesterol by clofibrate in patients with primary biliary cirrhosis. Gastroenterology 57, 253 (1969b).Google Scholar
  134. Schaffner, F. Serum cholesterol in primary biliary cirrhosis. Gastroenterology 56, 1111 (1969a).Google Scholar
  135. Schaffner, F., Klion, F. M., Latuff, A. J.: The long-term use of cholcstyramine in the treatment of primary biliary cirrhosis. Gastroenterology 48, 293 (1965).PubMedGoogle Scholar
  136. Schaffner, F., Popper, H.: Morphologic studies of cholestasis. Gastroenterology 37, 565 (1959).Google Scholar
  137. Schaffner, F., Popper, H.: Electron microscopy of small bile ducts in primary biliary cirrhosis. Amer. J. Path. 52, 14a (1968).Google Scholar
  138. Schapiro, R. H., Isselbacher, K. J.: Benign recurrent intrahepatic cholestasis. New Engl. J. Med. 268, 708 (1963).PubMedGoogle Scholar
  139. Scheuer, P.J.: Primary biliary cirrhosis. Proc. roy. Soc. Med. 60, 1257 (1967).PubMedGoogle Scholar
  140. Schoenfield, L. J., Sjövall, J., Perman, E.: Bile acids on the skin of patients with pruritic hepatobiliary disease. Nature (Lond.) 213, 93 (1967).Google Scholar
  141. Schwartz, S.J., Dale, W.A.: Primary sclerosing cholangitis. Review and report of six cases. Arch. Surg. 77, 439 (1959).Google Scholar
  142. Scobie, B. A., Summers Kill, W. H. J.: Hepatic cirrhosis secundary to obstruction of the biliary system. Amer. J. dig. Dis. 10, 135 (1965).PubMedGoogle Scholar
  143. Seidel, D., Alaupovic, P.: Ein abnormes Low-Density-Lipoprotein bei Cholestase. I. Isolierung und Charakterisierung. Dtsch. med. Wschr. 95, 1774 (1970).PubMedGoogle Scholar
  144. Seidel, D., Schmitt, E. A., Alaupovic, P.: Ein abnormes Low-Density-Lipoprotein bei Cholestase. II. Bedeutung in der Differentialdiagnose des Ikterus. Dtsch. med. Wschr. 95, 1805 (1970).PubMedGoogle Scholar
  145. Shear, L., Bankowsky, J.H., Gabuzda, G.L.: Renal tubular acidosis in cirrhosis. A determinant of susceptibility to recurrent hepatic precoma. New Engl. J. Med. 280, 1 (1969).PubMedGoogle Scholar
  146. Sherlock, S.: Primary biliary cirrhosis. (Chronic intrahepatic obstructive jaundice). Gastroenterology 37, 574 (1959).PubMedGoogle Scholar
  147. Sherlock, S.: Immunological aspects of active chronic hepatitis and primary biliary cirrhosis. Acta gastro-ent. belg. 31, 416 (1968).Google Scholar
  148. Sherlock, S.: Diseases of the liver and biliary system, 4. (Ed). Oxford-Edinburgh 1968.Google Scholar
  149. Smetana, H.F., Edlow, J.B., Gunz, P.R.: Neonatal jaundice: A critical review of persistent obstructive jaundice in infancy. Arch. Path. 80, 553 (1965).PubMedGoogle Scholar
  150. Sparberg, M., Simon, N., Del Greco, F.: Intrahepatic cholestasis due to azathioprine. Gastroenterology 57, 439 (1969).PubMedGoogle Scholar
  151. Stanley, N.N., Fox, R.A., Whimster, W. F., Sherlock, S., James, D.G.: Primary biliary cirrhosis or sarcoidosis — or both. New Engl. J. Med. 287, 1282 (1972).PubMedGoogle Scholar
  152. Stein, A.A., Wright, A. W.: Hepatic pathology in jaundice due to chlorpromazine. J. Amer. med. Ass. 161, 508 (1956).Google Scholar
  153. Stolzer, B. L., Miller, G., White, W. A., Zuckerbrod, M.: Postarsenical obstructive jaundice complicated by xanthomatosis and diabetes mellitus. Amer. J. Med. 9, 124 (1950).PubMedGoogle Scholar
  154. Summers Kill, W. H. J.: The syndrom of benign recurrent cholestasis. Amer. J. Med. 38, 298 (1965).Google Scholar
  155. Thannhauser, S. G., Magendantz, H.: The different clinical groups of xanthomatous diseases; physiological study of 22 cases. Ann. intern. Med. 11, 1662 (1958).Google Scholar
  156. Thomas, P. K., Walker, J. G.: Xanthomatous neuropathy in primary biliary cirrhosis. Brain 88, 1079 (1965).PubMedGoogle Scholar
  157. Tobias, H., Safran, A. P., Schaffner, F.: Lymphocyte stimulation and chronic liver diseases. Lancet 1967 I, 193.Google Scholar
  158. Trueman, A. M., Potter, B. J., Jones, E. A.: Serum compliment in primary biliary cirrhosis contrasted with chronic active hepatitis and cryptogenetic cirrhosis. 5. Meeting of the Int. Ass. for the study of the liver, Versailles 1972.Google Scholar
  159. Tumen, H.J., Cohn, E.M.: Cirrhosis. In: Bockus, H.L. (Ed.): Gastroenterology. Philadelphia-London: Saunders 1965.Google Scholar
  160. Tygstrup, N.: Intermittent possibly familial intrahepatic cholestatic jaundice. Lancet 1960 I, 1171.Google Scholar
  161. Ugarte, G., Iturriaga, H., Insunza, I.: Some effects of ethanol on normal and pathologic livers. In: Popper, H., Schaffner, F. (Eds.): Progress in liver diseases, p. 355. New York-London: Grune & Stratton 1970.Google Scholar
  162. Ulbricht, J.: Behandlung des ]uckreizes bei cholestatischer Hepatose und primärer biliärer Cirrhose. Münch. med. Wschr. 107, 231 (1965).PubMedGoogle Scholar
  163. Ungar, H., Moran, E., Elsner, M., Eliakim, M.: Rat intrahepatic biliary tract lesions from α:-naphthyl-isothiocyanate. Arch. Path. 73, 427 (1962).PubMedGoogle Scholar
  164. Van Itallie, T.B., Hashim, S.A., Crampton, R.S., Tennert, D.M.: The treatment of pruritus and hypercholesterolemia of primary biliary cirrhosis with colestyramine. New Engl. J. Med. 265, 469 (1961).Google Scholar
  165. Vinnick, J. E., Kern, F.: Biliary cirrhosis in a patient with chronic ulcerative colitis. Gastroenterology 45, 529 (1963).Google Scholar
  166. Vorländer, K. O.: Immunitat. In: Siegenthaler, W. (Hrsg.): Klinische Pathophysiologie. Stuttgart: Thieme 1970.Google Scholar
  167. Walker, J.G., Bates, D., Doniach, D., Ball, P.A.J., Sherlock, S.: Chronic liver disease and mitochondrial antibodies: A family study. Brit. med. J. 1972 I, 146.Google Scholar
  168. Walker, J. G., Doniach, D., Doniach, I.: Mitochondrial antibodies and subclinical liver disease. Zit. nach Berg, P.A. et al.: Klin. Wschr. 47, 1297 (1969).Google Scholar
  169. Walker, CH. 0., Combes, B.: Biliary cirrhosis induced by chlorpromazine. Gastroenterology 51, 631 (1966).PubMedGoogle Scholar
  170. Weber, F. P.: On biliary cirrhosis of the liver with and without cholelithiasis. Trans. path. Soc. (Lond.) 54, 103 (1902).Google Scholar
  171. Wepler, W.: Zur Ätiologie und Pathogenese der primären biliären Cirrhose. Rev. int. Hépat. 16, 2 (1966).Google Scholar
  172. Werner, S.C., Hanger, F.M., Kritzler, R.A.: Jaundice during methyltestosterone therapy. Amer. J. Med. 8, 325 (1950).PubMedGoogle Scholar
  173. Whelan, G., Sherlock, S.: Immunosuppressive activity in patients with active chronic hepatitis and primary biliary cirrhosis treated with azathioprine. Gut 13, 907 (1972).PubMedGoogle Scholar
  174. Whittingham, S., Irwin, J., Mackay, I.R., Smalley, M.: Smooth muscle autoantibody in “autoimmune” hepatitis. Gastroenterology 51, 499 (1966a).Google Scholar
  175. Whittingham, S., Mackay, I.R., Irwin, J.: Autoimmune hepatitis. Immunofluorescence reactions with cytoplasm of smooth muscle and renal glomerular cells. Lancet 1966 I, 1333.Google Scholar
  176. Wildhirt, E.: Cholestatischer Ikterus. In: Ergeb. inn. Med. Kinderheilk. N. F. 24, 80 (1966).Google Scholar
  177. Yuasa, D.: Beitrag zur Frage des Toluylendiamin-Ikterus. Beitr. path. Anat. 79, 713 (1928).Google Scholar
  178. Zelman, S.: Liver cell necrosis in chlorpromazine jaundice (allergic cholangiolitis). A serial study of twenty-six needle biopsy specimens in nine patients. Amer. J. Med. 27, 708 (1959).PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1974

Authors and Affiliations

  • H. A. Kühn
    • 1
  1. 1.Medizinischen Universitätsklinik WürzburgDeutschland

Personalised recommendations